Follow
Donal O'Shea
Donal O'Shea
St Vincent's University Hospital
Verified email at ucd.ie
Title
Cited by
Cited by
Year
A role for glucagon-like peptide-1 in the central regulation of feeding
MD Turton, D O'shea, I Gunn, SA Beak, CMB Edwards, K Meeran, SJ Choi, ...
Nature 379 (6560), 69-72, 1996
23731996
Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production
L Lynch, M Nowak, B Varghese, J Clark, AE Hogan, V Toxavidis, SP Balk, ...
Immunity 37 (3), 574-587, 2012
5462012
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight
M Rossi, SJ Choi, D O’shea, T Miyoshi, MA Ghatei, SR Bloom
Endocrinology 138 (1), 351-355, 1997
5301997
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
5042019
Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
X Michelet, L Dyck, A Hogan, RM Loftus, D Duquette, K Wei, S Beyaz, ...
Nature immunology 19 (12), 1330-1340, 2018
4902018
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7–36) amide or exendin-(9–39) alters body weight in the rat
K Meeran, D O’Shea, CMB Edwards, MD Turton, MM Heath, I Gunn, ...
Endocrinology 140 (1), 244-250, 1999
4241999
Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion …
TJ Cawood, PJ Hunt, D O'shea, D Cole, S Soule
European journal of endocrinology 161 (4), 513-527, 2009
3972009
Complications of obesity
D Kinlen, D Cody, D O’Shea
QJM: An International Journal of Medicine 111 (7), 437-443, 2018
3312018
Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity
L Lynch, D O'Shea, DC Winter, J Geoghegan, DG Doherty, C O'Farrelly
European journal of immunology 39 (7), 1893-1901, 2009
3032009
Interplay between the immune system and adipose tissue in obesity
MA Exley, L Hand, D O'Shea, L Lynch
Journal of Endocrinology 223 (2), R41-R48, 2014
2982014
Are natural killer cells protecting the metabolically healthy obese patient?
LA Lynch, JM O'connell, AK Kwasnik, TJ Cawood, C O'farrelly, DB O'shea
Obesity 17 (3), 601-605, 2009
2882009
The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity
J O'Connell, L Lynch, TJ Cawood, A Kwasnik, N Nolan, J Geoghegan, ...
PloS one 5 (4), e9997, 2010
2762010
Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link
TJ Cawood, P Moriarty, C O’Farrelly, D O’shea
The Journal of Clinical Endocrinology & Metabolism 92 (1), 59-64, 2007
2672007
Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study
K Meeran, D O’Shea, PD Upton, CJ Small, MA Ghatei, PH Byfield, ...
The Journal of Clinical Endocrinology & Metabolism 82 (1), 95-100, 1997
2651997
Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
AE Hogan, G Gaoatswe, L Lynch, MA Corrigan, C Woods, J O’Connell, ...
Diabetologia 57, 781-784, 2014
2042014
Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity
S Boulenouar, X Michelet, D Duquette, D Alvarez, AE Hogan, C Dold, ...
Immunity 46 (2), 273-286, 2017
1952017
Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke
D O'Shea, TJ Cawood, C O'Farrelly, L Lynch
PloS one 5 (1), e8660, 2010
1862010
Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells
BA Mangan, MR Dunne, VP O’Reilly, PJ Dunne, MA Exley, D O’Shea, ...
The Journal of Immunology 191 (1), 30-34, 2013
1812013
iNKT cells induce FGF21 for thermogenesis and are required for maximal weight loss in GLP1 therapy
L Lynch, AE Hogan, D Duquette, C Lester, A Banks, K LeClair, DE Cohen, ...
Cell metabolism 24 (3), 510-519, 2016
1792016
Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity
E Carolan, LM Tobin, BA Mangan, M Corrigan, G Gaoatswe, G Byrne, ...
The Journal of Immunology 194 (12), 5775-5780, 2015
1792015
The system can't perform the operation now. Try again later.
Articles 1–20